Resultados de la búsqueda
Rodriguez JM, Maquedano M, Cerdán-Vélez D, Laguillo-Gómez A, Calvo E, Abascal F, Vázquez J, Tress ML. An audit of the PeptideAtlas database uncovers evidence for repurposed pseudogenes and co-opted retroviral ORFs. BMC Genomics (2025) 26:1087
Martín-Morales C, Caspani S, Desco M, de Sousa CT, Gómez-Gaviro MV. Controlled Drug Release Systems for Cerebrovascular Diseases. ADV THER (2025) 8
Link to the full text in Repisalud
Link to the full text in Repisalud
Diaz-Arocutipa C, Bueno H, Moreno G, Olmos VJ, Vicent L. DIFFERENCES ON IN-HOSPITAL OUTCOMES IN PATIENTS WITH CARDIOGENIC SHOCK DUE TO STEMI VERSUS NSTEMI USING A NATIONWIDE DATABASE. Shock (2025) 63:36-42
Asensio-Lopez MDC, Ruiz-Ballester M, Pascual-Oliver S, Bastida-Nicolas FJ, Sassi Y, Fuster JJ, Pascual-Figal D, Soler F, Lax A. AEOL-induced NRF2 activation and DWORF overexpression mitigate myocardial I/R injury. Mol Med (2025) 31:189-208
Link to the full text in Repisalud
Link to the full text in Repisalud
Bobi J, Jimenez-Trinidad FR, Ortega-Paz L, Cortes-Serra N, Lazaro I, Rodriguez JJ, Fernandez-Becerra C, García-Álvarez A, Sabate M, Brugaletta S, Dantas AP. Antiangiogenic effect of circulating extracellular vesicles in acute coronary syndrome: Role of miR-199a-3p and miR-125a-5p. Eur J Clin Invest (2025) 55:e70022
Fernandes VS, Caballero R, Siguero-Álvarez M, Papoutsi T, Gimeno-Blanes JR, Delpón E, de la Pompa JL. Cardiac electrical abnormalities in a mouse model of left ventricular non-compaction cardiomyopathy. PLoS One (2025) 20:e0314840.
Link to the full text in Repisalud
Link to the full text in Repisalud
Mukherjee R, Lara-Pezzi E. est Paper of the Year 2024. J Cardiovasc Transl Res (2025) 18:1-2
Hira R, Baker JR, Siddiqui T, Patel A, Valani FGA, Lloyd MG, Floras JS, Morillo CA, Sheldon RS, Raj SR; Canadian Long COVID Autonomic Network (CanLoCAN). Attenuated cardiac autonomic function in patients with long-COVID with impaired orthostatic hemodynamics. CLIN AUTON RES (2025) 35:301-314
Soares FA, Salinas B, Reis S, Nunes C. Hyaluronic acid-engineered milk extracellular vesicles to target triple negative breast cancer through CD44. PHARM BIOL (2025) 63:411-427
Groun N, Villalba-Orero M, Casado-Martín L, Lara-Pezzi E, Valero E, Le Clainche S, Garicano-Mena J. Eigenhearts: Cardiac diseases classification using eigenfaces approach. Comput Biol Med (2025) 192:110167






